Investing.com - Viveve Medical reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Viveve Medical announced earnings per share of $-0.590 on revenue of $1.68M. Analysts polled by Investing.com anticipated EPS of $-0.660 on revenue of $1.68M.
Viveve Medical shares are down 53.92% from the beginning of the year and are trading at $0.525 , down-from-52-week-high.
Viveve Medical follows other major Healthcare sector earnings this month
Viveve Medical's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar